Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial-Reference-Cited by-同舟云学术

Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial

Published:2016-07 Issue:28 Volume:95 Page:e4174
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Dezzutti Charlene S.,Richardson-Harman Nicola,Rohan Lisa C.,Marzinke Mark A.,Hoesley Craig J.,Panther Lori,Johnson Sherri,Nuttall Jeremy P.,Nel Annalene,Chen Beatrice A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference47 articles.

1. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection;Abner;J Infect Dis,2005

2. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract;Collins;Nat Med,2000

3. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture;Cummins;Antimicrob Agents Chemother,2007

4. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice;Denton;PLoS Med,2008

5. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides;Fletcher;AIDS,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in Women;AIDS Research and Human Retroviruses;2022-12-01

2. A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study);AIDS Research and Human Retroviruses;2021-09-14

3. Design strategies for long-acting anti-HIV pharmaceuticals;Current Opinion in Pharmacology;2020-10

4. Mucosal Susceptibility to Human Immunodeficiency Virus Infection in the Proliferative and Secretory Phases of the Menstrual Cycle;AIDS Research and Human Retroviruses;2019-03

5. The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM;AIDS;2019-02-01